Quick Answer
Indivior Pharmaceuticals, Inc. reported Total Assets of $1.20 billion for fiscal year 2025.
Indivior Pharmaceuticals, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $1.20B | -8.7% |
| 2024 | $1.32B | -25.1% |
| 2023 | $1.76B | -0.6% |
| 2022 | $1.77B | -3.4% |
| 2021 | $1.83B | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $1.42B | — | -2.5% |
| June 30, 2025 | $1.45B | — | +5.6% |
| March 31, 2025 | $1.38B | — | +4.5% |
| December 31, 2024 | $1.32B | -25.1% | -25.1% |
| December 31, 2023 | $1.76B | — | — |
- Indivior Pharmaceuticals, Inc. showed a decrease of -8.7% in Total Assets compared to the prior fiscal year.
- Over the 2021–2025 period, Indivior Pharmaceuticals, Inc.’s total assets has declined by 34.4% (from $1.83 billion to $1.20 billion).
- The most recent figure is from Indivior Pharmaceuticals, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: